Sterling Financial Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,438
Closed -$105K 300
2021
Q3
$105K Sell
2,438
-6,864
-74% -$304K 0.07% 124
2021
Q2
$364K Sell
9,302
-1,396
-13% -$54.3K 0.24% 54
2021
Q1
$388K Buy
10,698
+2,521
+31% +$89.5K 0.28% 53
2020
Q4
$301K Buy
+8,177
New +$300K 0.24% 55

Other funds holding PFE

Sterling Financial Planning's PFE Position: Q4 2021 in Review

Sterling Financial Planning sold out of Pfizer (PFE) in Q4 2021, closing a stake of 2,438 shares — an estimated $105K sold.

Sterling Financial Planning first reported a position in PFE in Q4 2020 and held it in 4 quarters. The position peaked at $388K in Q1 2021. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Sterling Financial Planning reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
  • Sterling Financial Planning sold 2,438 Pfizer shares in Q4 2021, an estimated $105K.
  • Sterling Financial Planning first reported a position in Pfizer in Q4 2020 and held it in 4 quarters.
  • Sterling Financial Planning's Pfizer position peaked at $388K in Q1 2021.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Sterling Financial Planning's 13F filing for Q4 2021, filed 2 Feb 2022.